BKT140

Biorbyt

BKT140 [664334-36-5]

16

664334-36-5

Research Use Only

C97H144FN33O19S2

2159.52

Motixafortide (BKT140 4-fluorobenzoyl) is a novel CXCR4 antagonist with an IC50 vakue of ~1 nM.

O=C1[C@@]2([H])N(CCC2)C([C@@](NC([C@@H](NC([C@](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CCCNC(N)=N)NC([C@H](CCCNC(N)=N)NC(C3=CC=C(F)C=C3)=O)=O)=O)CC4=CC5=C(C=CC=C5)C=C4)=O)CSSC[C@](C(N[C@H](C(N)=O)CCCNC(N)=N)=O)([H])NC([C@H](CCCNC(N)=O)NC([C@@](CCCNC(N)=N)

12352200